baber/WOPTO huggingface dataset:
Patent EP-1798758-A4 (EP)
Title: Lighting optical device, regulation method for lighting optical device, exposure system, and exposure method
Inventor: TANAKA HIROHISA
IPC: G03F7/20
Filed: 2005-08-03
Abstract: An illumination optical apparatus is able to adjust each of pupil luminance distributions at respective points on a surface to be illuminated to being almost uniform, while maintaining or adjusting an illuminance distribution on the surface to be illuminated to being almost uniform. The illumination optical apparatus illuminates the surface to be illuminated (M, W), with a light beam from a light source (1). The apparatus is provided with a pupil distribution forming device (1-4) for forming a pupil luminance distribution with a predetermined luminance distribution on an illumination pupil plane; and an adjuster (8, 9) for independently adjusting each of pupil luminance distributions about respective points on the surface to be illuminated. The adjuster has a plurality of adjustment surfaces each of which is disposed in an optical path between the pupil distribution forming device and the surface to be illuminated and has a predetermined transmittance distribution or reflectance distribution.
Patent EP-1791971-A4 (EP)
Inventor: BLACK JENNIFER A
IPC: C12Q1/18
Filed: 2005-09-15
Abstract: L'invention concerne un procédé permettant de déterminer si un micro-organisme produit une AmpC ß-lactamase. Selon ce procédé, une culture de micro-organismes suspectés de produire une ß-lactamase qui inactive un antibiotique contenant une ß-lactame est mélangé à une quantité efficace de: i) un antibiotique contenant une ß-lactame, (ii) un inhibiteur de ß-lactamase auquel l'AmpC ß-lactamase est résistante, et (iii) un agent perméabilisant pour le micro-organisme présent dans une quantité perméabilisante de micro-organismes inhibant une non-croissance, de sorte à former une culture de dosage. Cette culture de dosage est maintenue dans des conditions de culture appropriées, pendant une durée suffisante pour déterminer l'interaction du micro-organisme avec l'inhibiteur résistant à l'AmpC ß-lactamase et un composé antibactérien, ce qui permet de déterminer la présence d'une AmpC ß-lactamase, un test positif indiquant la présence de cette enzyme.
Patent EP-1803302-A4 (EP)
Inventor: HAN WOO-JIN
IPC: H04N7/24
Filed: 2005-09-28
Abstract: L'invention concerne un procédé et un dispositif qui permettent d'appliquer un codage hiérarchique au rapport signal sur bruit (SNR) dans un serveur de flux de données vidéo pour transmettre un flux de données dans un environnement réseau variable. Un dispositif permettant d'adapter un débit binaire d'un train binaire codé évolutif par multicouches à un environnement réseau variable comprend: une unité d'analyse de train binaire pour analyser un train binaire; une unité de détermination de la condition de prédécodage pour déterminer un débit binaire de transmission cible conformément à l'environnement réseau variable; une unité de prédécodage pour sauter au moins une trame sur l'ensemble des trames contenues dans le train binaire analysé conformément au débit binaire cible déterminé; et enfin, une unité de transmission de train binaire pour transmettre à un dispositif client le train binaire restructuré consécutivement au saut de trame.
Patent EP-1825014-A4 (EP)
Title: Steel with excellent weather resistance at the seaside atmosphere, and manufacturing method therefor
Inventor: JUNG HWAN-GYO
IPC: C22C1/06
Filed: 2005-09-28
Abstract: The invention relates to steel with excellent weather resistance, and a manufacturing method therefor. According to the invention, the steel consists of up to 0.15wt% C, up to 1.0wt% Si, up to 2.0wt% Mn, 0.2 to 1.0wt% Cu, 0.2 to 5.0wt% Ni, 0.001 to 0.1 wt% Al, up to 0.03wt% P, 0.002 to 0.03wt%S, 0.001 to 0.01wt% Ca. The balance contains Fe and unavoidable impurities, and Ca, S, Al, Si contents are determined by an Equation 1 Ca(%)/S(%) > 1.5Al(%)+2Si(%). Also, the steel has at least 30wt% water-soluble CaS inclusion out of Ca-based non-metallic inclusions. The invention provides steel with excellent weather resistance in an atmosphere having a high concentration of salinity.
Patent EP-1882738-A4 (EP)
Inventor: HASHIGUCHI SATOSHI
IPC: C12N1/02
Filed: 2006-05-19
Abstract: 簡便かつ、回収率に優れる微生物及び核酸の回収方法を提供する。
　本発明の微生物の回収方法は、微粒子と試料とを接触させ、前記試料中の微生物を微粒子に吸着させる微生物吸着工程を含み、前記微粒子の粒子径が６μｍ以下であり、かつ、その比表面積が５０ｍ2／ｇ以下であることを特徴とする。また、本発明の核酸の回収方法は、試料中の微生物を微粒子に吸着させる微生物吸着工程と、前記微粒子に吸着させた微生物から核酸を溶出させる核酸溶出工程とを含み、前記微生物吸着工程が、本発明の微生物回収方法であることを特徴とする。本発明の回収方法によれば、微生物及び核酸を簡便かつ効率よく回収できる。前記微粒子は、磁性シリカ粒子が好ましい。
Patent EP-1895449-A4 (EP)
Inventor: OTA TOYOKAZU
IPC: H04B1/59
Filed: 2006-06-19
Abstract: カード読み書き機能を備えた装置と、ＩＣカードと有線接続された情報端末の間で、大容量のデータの高速転送を行なう。
　情報処理端末はＩＣカードを介在させた非接触データ通信を許容するデータ転送状態と、この非接触データ通信を許容しない非データ転送状態とを定義し、ＩＣカードが情報処理端末の通信状態を管理する。ＩＣカードは、情報処理端末からの通知に依らず、データ転送状態又はデータ非転送状態のいずれであるかに応じて端末側へデータ転送を行なうことができるので、同期をとり易く、転送速度を高速化することができ、大容量のデータ転送が実現可能となる。
Patent EP-2159709-A4 (EP)
Title: Error correcting method and computing element
Inventor: OHNUKI YOSHITERU
IPC: G11C29/42
Filed: 2007-06-15
Abstract: [Object] The object of an embodiment is to provide an error correcting method that executes an error correction of a register file without lowering the processing speed of a CPU in an information processing apparatus.  [Solving Means] An error correcting method of an embodiment is an error correcting method in which a register provided in a computing element holds data and check data and corrects an error generated in the data. The error correcting method is  characterized by  including a detection step for detecting an error of the data by using the check data by the computing element, and a correction step for correcting the error detected in the data by using correction data different from the check data by the computing element.
Patent EP-2058303-A4 (EP)
Title: Method for producing piperidin-4-one-derivative
Inventor: OOOKA HIROHITO
IPC: C07D491/113
Filed: 2007-10-10
Abstract: Provided is a method for producing a piperidin-4-one derivative useful as an intermediate for agricultural chemicals or pharmaceutical products. A piperidin-4-one derivative represented by formula (III-a) or formula (III-b) is produced by reacting a cyclic bis(aminol)ether compound represented by formula (I) and an acetone derivative represented by formula (II) in the presence of at least one substance selected from the group consisting of protonic acids, Lewis acids, acid halides and dialkyl sulfuric acids.
Patent EP-2106409-A4 (EP)
Title: Vinylidene fluoride copolymer composition with improved low-temperature impact properties
Inventor: WILLE ROICE A
IPC: C08F2/00
Filed: 2007-12-07
Abstract: This invention relates to a heterogeneous copolymer composition of polyvinylidene fluoride with one or more perfluoroalkyl ethers. These copolymers have excellent low temperature impact properties, while maintaining a high melting point.
Patent EP-2097835-A4 (EP)
Title: Patient-based parameter generation systems for medical injection procedures
Inventor: KALAFUT JOHN
IPC: G16H20/17
Filed: 2007-12-21
Abstract: A system includes a parameter generation system to determine parameters of at least one phase of an injection procedure based at least in part upon a type of the injection procedure. The parameter generator system determines the amount of a pharmaceutical that is to be delivered to a patient at least in part on the basis of the concentration of an agent in the pharmaceutical and at least on part on the basis of a function that depends upon and varies with a patient parameter. The patient parameter can, for example, be weight, body mass index, body surface area or cardiac output. The pharmaceutical can, for example, include a contrast enhancing agent for use in an imaging procedure.
Patent EP-2237641-A4 (EP)
Title: Electromagnetic induction heating device
Inventor: HAYASHI TAKAKAZU
IPC: H05B6/06
Filed: 2008-11-07
Abstract: Provided is a low cost and highly safe electromagnetic induction heating device capable of uniformly heating an object to be heated. A work coil (26) has a basic coil (28) located at the innermost position, a first coil (30) located at the intermediate position, and a second coil (32) located at the outermost position, the latter two coils being connected in series to the basic coil (28). The first coil (30) and the second coil (32) are connected in parallel to each other. A switching circuit (16) for supplying a high-frequency current is connected to the first coil 30, and a second switching circuit 18 for supplying a high-frequency current is connected to the second coil 32.
Patent EP-2279388-A4 (EP)
Title: Methods and apparatus for high-impulse fuze booster
Inventor: BERLIN BRYAN F
IPC: F42B3/22
Filed: 2009-04-24
Abstract: A method for initiating a low-sensitivity explosive charge includes initiating a booster explosive charge within an explosive charge cavity in a booster housing, and generating a planar detonation wave. Generating the planar detonation wave includes directing a detonation wave through the booster housing along a first waveshaper surface of a detonation waveshaper. The detonation wave is directed around the first waveshaper surface toward a second tapered waveshaper surface. After progressing around the first waveshaper surface, the detonation wave is directed along the second tapered waveshaper surface. The detonation wave changes into a planar detonation wave as the detonation wave moves along the second tapered waveshaper surface, the planar detonation wave includes a planar wave front. The planar detonation wave strikes a flyer plate coupled over the explosive charge cavity of the booster housing, and the planar wave front makes planar contact along an inner face of the flyer plate.
Patent EP-2601901-A4 (EP)
Title: Ultrasound therapy device
Inventor: SANAI HIDEO
IPC: A61B17/32
Filed: 2012-03-12
Abstract: An ultrasonic treatment device includes a first path defining portion defining a first path that is opened at an opening position at a distal end portion of a probe, and a second path defining portion defining a second path communicating with the first path outside a treatment unit. The first path is extended to a bending position located to a distal direction side of a first coupling region in the probe along a longitudinal axis, and is extended to an outside of the treatment unit through an outer peripheral portion of the probe by bending at the bending position. The second path defining portion is extended in a fixed handle of a handle unit from the outside of the treatment unit along a handle extending direction.
Patent EP-0077352-A4 (EP)
Title: Acoustic degasification of pressurized liquids.
Inventor: FAULKNER LYNN
IPC: B01D/
Filed: 1982-03-12
Abstract: Acoustic degasification process and apparatus for separating dissolved gases form hydropressured or geopressured liquids. The liquid and the dissolved gas flow through a hollow chamber that is vibrated utilizing acoustic energy so as to focus the acoustic energy near the center of the hollow chamber, and by the process of rectified diffusion bubbles form and grow within the liquid, wherein buoyancy forces cause the enlarging bubbles to migrate to the surface of the liquid.
Patent EP-0137786-A4 (EP)
Title: Hyaluronic acid from bacterial culture.
Inventor: BRACKE JAMES W
IPC: C12P19/26
Filed: 1983-09-16
Abstract: Hyaluronic acid, a polysaccharide, is prepared in high yield from streptococcus bacteria by fermenting the bacteria under anaerobic conditions in a CO2-enriched growth medium, separating the bacteria from the resulting broth and isolating the hyaluronic acid from the remaining constituents of the broth. The bacteria may be grown free of endotoxins by filtering all ingredients through a 10K Millipore TM filter prior to inoculation of the medium and subsequently maintaining pyrogen-free conditions. Separation of the microorganisms from the polysaccharide is facilitated by killing the bacteria with trichloroacetic acid. After removal of the bacterial cells and concentration of the higher molecular weight fermentation products, the hyaluronic acid is isolated and purified by precipitation, resuspension and reprecipitation.
Patent EP-0143800-A4 (EP)
Title: An improved magnetic seal assembly.
Inventor: MACLEOD DONALD J
IPC: F16J15/43
Filed: 1984-03-29
Abstract: An improved magnetic liquid seal assembly (10) including an inner magnetic ring (18) concentrically bonded to the shaft (12), an outer magnetic ring (20) concentrically surrounding the inner magnetic ring (18) with a uniform air gap (22) therebetween and a quantity of magnetic fluid (24) disposed about the air gap (22) such that there is no passage of air or debris through the air gap (22). The inner and outer magnetic rings (18 and 20) are permanently magnetized units while the magnetic fluid (24) is a suspension of permanently magnetized particles in a carrier fluid. The direction of polarization in both the inner and outer magnetic rings (18 and 20) is parallel to the axis of the shaft (12), but is opposite in the two rings, at least in the vicinity of the air gap (22). In the preferred embodiment, the magnetic rings (18 and 20) are provided with iron pole pieces (26) on the planar surfaces to intensify the field strength. Furthermore, both the inner and outer magnetic rings (18 and 20) are provided with surface magnetizations in the nature of guard rings (28 and 30) which prevent the magnetic fluid (24) from migrating along the surface of the pole piece (26) to either the shaft (12) or the housing (16). The primary use of the improved seal (10) is in disk drive assemblies in the data processing and computer peripheral industries.
Patent EP-0157860-A4 (EP)
Inventor: BREDDAN JOSEPH ABRAHAM
IPC: H02J3/00
Filed: 1984-10-02
Abstract: Ce système de régulation de dispositif offre un nouveau procédé pour déterminer si des charges consommant des ressources (L1-Lk) doivent être mises hors service pour empêcher la consommation totale de ressources de dépasser un seuil prédéterminé. Ce système base le procédé de prise de décision sur un paramètre de risque réglable par le client (103), la consommation passée, l'activité de délestage passée et l'activité de charge future prédite. L'algorithme de régulation est appliqué à la situation de consommation de ressources actuelles pour une pluralité de différents intervalles de temps et l'on utilise le pire cas résultant de ces calculs pour réguler le délestage.
Patent EP-0215131-A4 (EP)
Title: E87Ag ANTIGEN OF PSEUDOMONAS AERUGINOSA, MONOCLONAL ANTIBODY AGAINST IT, AND HYBRIDOMA.
Inventor: SAWADA SHUZO
IPC: A61K39/395
Filed: 1986-03-10
Abstract: P. aeruginosa E87Ag antigen comprising polysaccharide fraction with molecular weight of about 27,000 which is contained in lipopolysaccharide of P. aeruginosa; anti-P. aeruginosa human or mouse monoclonal antibody which recognizes said E87Ag antigen; and mouse-human or mouse-mouse hybridoma which produces said monoclonal antibody. The monoclonal antibody can be used for making diagnosis and therapy of infections with P. aeruginosa.
Patent EP-0261230-A4 (EP)
Inventor: BROADWIN ALAN
IPC: A61B18/00
Filed: 1987-04-02
Abstract: Un procédé et un appareil, servant à interrompre périodiquement l'énergie ultrasonore appliquée à une pointe (11) à vibrations par ultrasons dans le but de réguler son amplitude entre une amplitude élevée et une amplitude faible ou égale à zéro avec un coefficient d'utilisation et une vitesse de répétition au choix, permettent une fragmentation et un réglage chirurgical améliorés. Le coefficient d'utilisation peut également varier en fonction d'un paramètre détecté à distance, tel que la température des tissus.
Patent EP-0323963-A4 (EP)
Title: Flangeless transmitter coupling to a flange adapter union
IPC: G01L/
Filed: 1987-09-03
Abstract: A pressure transmitter is coupled directly to an industry standard flange adapter union having a standard bolt hole spacing. Small diameter isolator diaphragms are positioned on the transmitter housing at locations so that the industry standard flange adapter union which couple fluid pressure sources to act on the isolator diaphragms without an intermediate large flange or manifold as is presently required and using the fasteners for the adapter union to complete the coupling. The smaller isolaters fit within the bolt hole spacing of the industry standard adapter union.
Patent EP-0312617-A4 (EP)
Title: Method of obtaining polypeptides in cell-free translation system.
Inventor: ALAKHOV JULY BORISOVICH
IPC: C12P21/02
Filed: 1988-04-14
Abstract: Polypeptides are obtained in a cell-free translation system on ribosomes which contains, as substrates, ATP, GTP and amino acids with the resulting translation products containing the desired product, AMP, GDP, pyrophosphate and inorganic phosphate. In the course of the translation process, as the substrates are consumed and the products are obtained, the products of translation including AMP, GDP, pyrophosphate, inorganic phosphate and the desired product are extracted from the system, while simultaneously introducing in the system substrates in the form of amino acids, ATP and GTP for the purpose of maintaining their initial concentration.
Patent EP-0376970-A4 (EP)
Title: Vehicle moving apparatus
IPC: B60S13/02
Filed: 1988-07-22
Abstract: Vehicle moving apparatus comprises counter-rotating wheels (12, 23, 24, 34, 41, 53) and rollers (14, 21, 22, 38, 42, 52) having spaced axes to enable the rollers (14, 21, 22, 38, 42, 52) to engage a peripheral surface of a vehicle wheel (16, 19, 39, 54, 61) with the wheels (12, 23, 24, 34, 41, 53) in ground contact. Driving means causes the wheels (12, 23, 24, 34, 41, 53) and rollers (14, 21, 22, 38, 42, 52) which are carried by a suitable support frame (26, 33) to wedge against the vehicle wheel and provide a driving force thereto.
Patent EP-0467929-A4 (EP)
Title: Method and apparatus for waste treatment
IPC: B02C18/14
Filed: 1990-04-12
Abstract: PCT No. PCT/AU90/00149 Sec. 371 Date Dec. 5, 1991 Sec. 102(e) Date Dec. 5, 1991 PCT Filed Apr. 12, 1989 PCT Pub. No. WO90/12251 PCT Pub. Date Oct. 18, 1990.A method of treatment of waste material includes the steps of mixing the waste material with binder and pelletizing the mixture. The pellets are then coated with a non-agglomerating material selected to permit firing of the mixture without pellet agglomeration at a temperature above 1300 DEG  C. The coated pellets are fed to a kiln and fired at a temperature above 1300 DEG  C. before being discharged from the kiln. At least some of the heat of firing the pellets is recovered and recycled to the kiln.
Patent EP-0470978-A4 (EP)
Title: Improved jointing of building panels and sheets
IPC: B27F1/00
Filed: 1990-05-02
Abstract: An improved panel jointing system wherein panels (10, 11) are provided with profiled edge portions comprising tongue formations (12) and recesses (13) which are of complementary shape to the tongues (12), the tongues (12) of one panel being receivable in the recesses (13) of another panel, wherein the profiled edge portions comprise integrally formed projections (15, 16) projecting from the edge surfaces of the tongues (12) and/or from the walls forming the recesses (13), the tongues (12), recesses (13) and projections (15, 16) being shaped and dimensioned so that, when the tongues are received in the recesses, the tongues (12) form a friction fit with the recesses (13), and the opposed facing surfaces of the tongues (12) and the walls of the recesses (13) being spaced apart so as to form a gap (18) of approximately uniform width which extends along the joint between the panels, interrupted by the projections (15, 16), the gap being fillable with adhesive.
Patent EP-0485616-A4 (EP)
Title: Oral composition
IPC: A61Q11/00
Filed: 1991-05-23
Abstract: An oral composition comprising cetylpyridinium chloride and a lower alkyl ester of an N< alpha >-(long-chain acyl)-substituted basic amino acid or its salt. The composition serves to promote the adsorption of cetylpyridinium chloride on the surfaces of teeth to exhibit an excellent effect in preventing dental plaque and dental caries.
Patent EP-0491930-A4 (EP)
Title: Primate lentivirus vaccines
IPC: C07K14/155
Filed: 1991-07-10
Abstract: Molecular clones of primate lentiviruses that harbor an engineered non-revertible null mutation in the nef gene and which may further include a non-revertible null mutation in one or more of the NRE, vpr, vpx, and/or vpu sequences are disclosed. Intact viruses containing such mutant genomes are also disclosed. These infectious, nonpathogenic viruses are capable of eliciting a protective host immune response and, thus, are useful as a vaccine that protects against AIDS in human subjects.
Patent EP-0503015-A4 (EP)
IPC: H01L31/05
Filed: 1991-08-09
Abstract: Des cellules voltaïques pourvues de contacts électriques à couche épaisse et riches en argent, et présentant des caractéristiques de vieillissement thermique améliorées sont décrites. Des fils électriques sont fixés aux contacts à couche épaisse et riches en argent par l'intermédiaire d'une pâte à braser en argent et étain comprenant environ 96 % d'étain/4 % d'argent à 98 % d'étain/2 % d'argent. Des cellules solaires possédant des connexions brasées de la présente invention sont capables de résister à des températures d'environ 150 °C avec peu ou pas de détérioration des connexions brasées pendant des périodes beaucoup plus longues que les cellules conventionnelles.
Patent EP-0538416-A4 (EP)
Title: Substituted monocyclic aryl compounds exhibiting selective leukotriene b 4? antagonist activity
Inventor: HUANG FU-CHIH
IPC: A61K31/194
Filed: 1991-09-06
Abstract: Monocyclic aryl compounds having selective LTB4 antagonists properties and comprising an amido substituent, a substituent group having a terminal carboxylic acid or derivative thereof and a lipophilic substituent, therapeutic compositions and methods of treatment of disorders which result from LTB4 activity using the monocyclic aryl compounds are disclosed.
Patent EP-0555343-A4 (EP)
Title: Device for intratracheal and intratracheal pulmonary ventilation
IPC: A61M16/00
Filed: 1991-10-31
Abstract: A method and apparatus for intratracheal ventilation (ITV) and intratracheal pulmonary ventilation (ITPV) in which a catheter positioned in a patient's trachea at the carina supplies a constant supply of fresh oxygen containing gas to flush anatomical dead space. By positioning the catheter in the patient's trachea, the dead space of the trachea is bypassed and the trachea is only utilized for expiration. By providing a timed expiratory valve in the ITPV mode, lower pressures and fresh oxygen flow rates may be utilized with respiratory rates from 10 to 120 breaths per minute or higher. The catheter has a diffuser tip, and the patient is ventilated at a flow rate between 0.54 to 4 times the anatomical dead space per breath.
Patent EP-0621840-A4 (EP)
Title: Rear suspension for bicycles.
Inventor: LEITNER HORST
IPC: B62K25/30
Filed: 1993-01-21
Abstract: A rear wheel suspension for a bicycle includes paired lower arm members (2, 102) pivotally connected to the bicycle frame seat tube (14) such that they can pivot about an axis (20) situated above the center of the bottom bracket, paired upper arm members (3, 103) adapted to receive the rear wheel axle (24) at hub points located on an axis situated above their lower ends and pivotally connected to the respective lower arm members such that they can pivot about an axis (4) near the rear ends of the lower arm members, and a device (5 or 10) associated with the upper ends of the upper arm members and pivotally connected to an upper pivot point (6) on the seat tube for limiting the path and the extent of movement of the upper ends of the upper arm members.